Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium

Jennifer Seminara, Mendel Tuchman, Lauren Krivitzky, Jeffrey Krischer, Hye Seung Lee, Cynthia LeMons, Matthias Baumgartner, Stephen Cederbaum, George A. Diaz, Annette Feigenbaum, Renata C. Gallagher, Cary O. Harding, Douglas S. Kerr, Brendan Lanpher, Brendan Lee, Uta Lichter-Konecki, Shawn E. McCandless, J. Lawrence Merritt, Mary Lou Oster-Granite, Margretta R. SeashoreTamar Stricker, Marshall Summar, Susan Waisbren, Marc Yudkoff, Mark L. Batshaw

Research output: Contribution to journalReview articlepeer-review

70 Scopus citations


The Urea Cycle Disorders Consortium (UCDC) was created as part of a larger network established by the National Institutes of Health to study rare diseases. This paper reviews the UCDC's accomplishments over the first 6 years, including how the Consortium was developed and organized, clinical research studies initiated, and the importance of creating partnerships with patient advocacy groups, philanthropic foundations and biotech and pharmaceutical companies.

Original languageEnglish
Pages (from-to)S97-S105
JournalMolecular Genetics and Metabolism
Issue numberSUPPL.
StatePublished - 2010


  • Rare disease
  • Urea cycle disorder


Dive into the research topics of 'Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium'. Together they form a unique fingerprint.

Cite this